University of California San Francisco

Biography

Jasmine M. Wong, M.D., is an Assistant Professor of Clinical Surgery in the UCSF Department of Surgery and specializes in breast surgery. She is a member of the multidisciplinary breast care team at the UCSF Breast Care Center in the UCSF Helen Diller Family Comprehensive Cancer Center. She also practices breast surgery and is a member of the multidisciplinary breast care team at San Francisco General Hospital.

Dr. Wong received her undergraduate degree from Washington University in St. Louis and her medical degree from St. Louis University School of Medicine. After completing her general surgery residency at Loma Linda University Medical Center, she completed her breast surgical oncology fellowship at UCSF.

Dr. Wong is board certified by the American Board of Surgery and is a member of the American College of Surgeons.

Education

Education

Washington University in St. Louis, B.A., 2003 
St. Louis University School of Medicine, M.D., 2008 
 

Residencies

Loma Linda University Medical Center, General Surgery, 2008-2012 
Loma Linda University Medical Center, General Surgery, Chief Resident, 2012-2013

Fellowships

Breast Surgical Oncology, University of California, San Francisco, 2013-2014

Board Certifications

American Board of Surgery, General Surgery

Clinical Expertise

DCIS (ductal carcinoma in situ)

LCIS (lobular carcinoma in situ)

Invasive breast cancer

Recurrent breast cancer

Lumpectomy/partial mastectomy

Mastectomy

Sentinel lymph node biopsy

Wire localization surgery

Program Affiliations

Member, UCSF Helen Diller Family Comprehensive Cancer Center

Member, Carol Franc Buck Breast Care Center

In the News

Jasmine Wong Leads UCSF Study of Novel Diagnostic Agent, AVB-620, in Breast Cancer
November, 04, 2015 | UCSF Department of Surgery
Letting Patients Call the Shots
March, 19, 2015 | Kaiser Health News (KHN)

Research Interests

DCIS

Tumor margin assessment tools

 

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 12
  1. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
    Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA| | PubMed
  2. Utility and Outcomes of Preoperative Screening Breast MRI for Planned Bilateral Prophylactic Mastectomy in High-Risk Patients.
    Taliaferro AS, Price ER, Hayward JH, Wong JM, Balassanian R, Fay JS, Freimanis RI, Joe BN, Lee AY| | PubMed
  3. Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.
    Hewitt KC, Miller P, Piper M, Prionas N, Son JD, Alvarado M, Esserman LJ, Wong JM, Ewing C, Mukhtar RA| | PubMed
  4. Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection.
    Glencer AC, Wong JM, Hylton NM, Krings G, McCune E, Rothschild HT, Loveday TA, Alvarado MD, Esserman LJ, Campbell MJ| | PubMed
  5. Intermediary clip placement to assist accurate axillary lymph node localization.
    Price ER, Vyas S, Lee AY, Wong JM, Joe BN, Ray KM| | PubMed
  6. Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience.
    Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, Wong JM, Mukhtar RA| | PubMed
  7. Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment.
    Greenwood HI, Wong JM, Mukhtar RA, Alvarado MD, Price ER| | PubMed
  8. Changes in mammographic density following bariatric surgery.
    Hosseini A, Khoury AL, Varghese F, Carter J, Wong JM, Mukhtar RA| | PubMed
  9. Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
    Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, I-SPY2 Investigators| | PubMed
  10. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
    Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, and I-SPY 2 Investigators| | PubMed
  11. Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care.
    Mukhtar RA, Wong JM, Esserman LJ| | PubMed
  12. Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma.
    Wanis ML, Wong JA, Rodriguez S, Wong JM, Jabo B, Ashok A, Lum SS, Solomon NL, Reeves ME, Garberoglio CA, Senthil M| | PubMed